Pivotal Therapeutics Inc.
PVTTF
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 31.43% | -22.77% | -3,035.98% | 102.19% | 24.77% |
| Total Depreciation and Amortization | -5.88% | 2.12% | 23.04% | -8.73% | 1.20% |
| Total Amortization of Deferred Charges | 0.61% | 7.66% | -74.27% | -- | 100.00% |
| Total Other Non-Cash Items | -71.46% | 116.32% | 106.87% | -474.09% | -12.94% |
| Change in Net Operating Assets | -21.52% | 74.98% | 318.63% | 12.14% | -120.11% |
| Cash from Operations | 121.12% | 71.67% | 64.01% | 45.84% | 24.57% |
| Capital Expenditure | -- | 100.00% | -26.14% | 70.76% | 41.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.88% | 56.42% | 31.55% | -463.11% | 68.69% |
| Cash from Investing | 76.88% | 66.01% | 23.80% | -65.35% | 52.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.95% | 70.62% | 66.71% | 31.03% | 25.95% |